RaySearch Laboratories AB (RSLBF) Stock Statistics & Valuation Metrics
Total Valuation
RaySearch Laboratories AB has a market cap or net worth of $708.41M. The enterprise value is $7.68B.
- Market Cap
- $708.41M
- Enterprise Value
- $7.68B
Share Statistics
RaySearch Laboratories AB has 30,799,536 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 30,799,536
- Owned by Insiders
- ―
- Owned by Institutions
- 7.06%
Financial Efficiency
RaySearch Laboratories AB’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 16.99%.
- Return on Equity (ROE)
- 0.23
- Return on Assets (ROA)
- 0.11
- Return on Invested Capital (ROIC)
- 16.99%
- Return on Capital Employed (ROCE)
- 0.23
- Revenue Per Employee
- 2.90M
- Profits Per Employee
- 490.95K
- Employee Count
- 464
- Asset Turnover
- 0.67
- Inventory Turnover
- 17.86
Valuation Ratios
The current PE Ratio of RaySearch Laboratories AB is 32.66. RaySearch Laboratories AB’s PEG ratio is 3.17.
- PE Ratio
- 32.66
- PS Ratio
- 4.81
- PB Ratio
- 8.80
- Price to FCF
- 17.92
- Price to Operating Cash Flow
- 16.86
- PEG Ratio
- 3.17
Income Statement
In the last 12 months, RaySearch Laboratories AB had revenue of 1.34B and earned 227.80M in profits. Earnings per share was 6.65.
- Revenue
- 1.34B
- Gross Profit
- 951.40M
- Operating Income
- 321.80M
- Pretax Income
- 287.80M
- Net Income
- 227.80M
- EBITDA
- 612.80M
- Earnings Per Share (EPS)
- 6.65
Cash Flow
In the last 12 months, operating cash flow was 411.80M and capital expenditures -70.70M, giving a free cash flow of 341.10M billion.
- Operating Cash Flow
- 411.80M
- Free Cash Flow
- 341.10M
- Free Cash Flow per Share
- 9.97
Dividends & Yields
RaySearch Laboratories AB pays an annual dividend of $0.43, resulting in a dividend yield of 1.62%
- Dividend Per Share
- $0.43
- Dividend Yield
- 1.62%
- Payout Ratio
- 64.49%
- Free Cash Flow Yield
- 5.58%
- Earnings Yield
- 3.07%
Stock Price Statistics
- Beta
- 0.71
- 52-Week Price Change
- -13.97%
- 50-Day Moving Average
- 18.70
- 200-Day Moving Average
- 20.13
- Relative Strength Index (RSI)
- 65.36
- Average Volume (3m)
- 642
Important Dates
RaySearch Laboratories AB upcoming earnings date is Nov 03, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 03, 2026
- Ex-Dividend Date
- May 11, 2026
Financial Position
RaySearch Laboratories AB as a current ratio of 1.70, with Debt / Equity ratio of 40.07%
- Current Ratio
- 1.70
- Quick Ratio
- 1.66
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.02
- Interest Coverage Ratio
- 41.26
Taxes
In the past 12 months, RaySearch Laboratories AB has paid 60.00M in taxes.
- Income Tax
- 60.00M
- Effective Tax Rate
- 0.21
Enterprise Valuation
RaySearch Laboratories AB EV to EBITDA ratio is 13.03, with an EV/FCF ratio of 18.34.
- EV to Sales
- 4.93
- EV to EBITDA
- 13.03
- EV to Free Cash Flow
- 18.34
- EV to Operating Cash Flow
- 15.20
Balance Sheet
RaySearch Laboratories AB has $213.10M in cash and marketable securities with $359.20M in debt, giving a net cash position of -$146.10M billion.
- Cash & Marketable Securities
- $213.10M
- Total Debt
- $359.20M
- Net Cash
- -$146.10M
- Net Cash Per Share
- -$4.74
- Tangible Book Value Per Share
- $5.76
Margins
Gross margin is 76.22%, with operating margin of 21.05%, and net profit margin of 16.77%.
- Gross Margin
- 76.22%
- Operating Margin
- 21.05%
- Pretax Margin
- 21.37%
- Net Profit Margin
- 16.77%
- EBITDA Margin
- 37.81%
- EBIT Margin
- 21.04%
Analyst Forecast
The average price target for RaySearch Laboratories AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 12.41%
- EPS Growth Forecast
- 23.39%
